His Confidence interval research extends to Internal medicine, which is thematically connected. Aurel Perren integrates Confidence interval with Hazard ratio in his research. Aurel Perren combines Oncology and Cancer research in his research. Aurel Perren performs multidisciplinary study in the fields of Cancer research and Oncology via his papers. In his research, he undertakes multidisciplinary study on General surgery and Pathology. He connects Pathology with General surgery in his research. His study deals with a combination of Pancreas and Hormone. He conducts interdisciplinary study in the fields of Hormone and Endocrine system through his works. Borrowing concepts from Pancreas, he weaves in ideas under Endocrine system.
Aurel Perren incorporates a variety of subjects into his writings, including Paleontology, Stage (stratigraphy) and Botany. Aurel Perren merges Botany with Paleontology in his study. He connects Internal medicine with General surgery in his research. In his research, Aurel Perren undertakes multidisciplinary study on General surgery and Internal medicine. Aurel Perren combines topics linked to Carcinoma with his work on Pathology. His Carcinoma study frequently links to other fields, such as Pathology. In his research, he performs multidisciplinary study on Cancer research and Tumor suppressor gene. Aurel Perren performs multidisciplinary studies into Tumor suppressor gene and Carcinogenesis in his work. In his works, he undertakes multidisciplinary study on Carcinogenesis and Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system
G. Rindi;G. Klöppel;H. Alhman;M. Caplin.
Virchows Archiv (2006)
TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system
G. Rindi;G. Klöppel;A. Couvelard;P. Komminoth.
Virchows Archiv (2007)
The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification.
Günter Klöppel;Aurel Perren;Aurel Perren;Philipp U. Heitz;Philipp U. Heitz.
Annals of the New York Academy of Sciences (2004)
Increased Number of Islet-Associated Macrophages in Type 2 Diabetes
Jan A. Ehses;Aurel Perren;Elisabeth Eppler;Pascale Ribaux.
Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
K. Öberg;U. Knigge;D. Kwekkeboom;A. Perren.
Annals of Oncology (2012)
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.
Francien H van Nederveen;José Gaal;Judith Favier;Esther Korpershoek.
Lancet Oncology (2009)
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids
Martyn E. Caplin;E. Baudin;P. Ferolla;P. Filosso.
Annals of Oncology (2015)
Immunohistochemical Evidence of Loss of PTEN Expression in Primary Ductal Adenocarcinomas of the Breast
Aurel Perren;Liang Ping Weng;Alexander H. Boag;Ulricke Ziebold.
American Journal of Pathology (1999)
TNM Staging of Neoplasms of the Endocrine Pancreas: Results From a Large International Cohort Study
Guido Rindi;M Falconi;C Klersy;L Albarello.
Journal of the National Cancer Institute (2012)
ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas
R. Garcia-Carbonero;H. Sorbye;E. Baudin;E. Raymond.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: